Peel Hunt Reiterates Add Rating for Udg Healthcare (UDG)

Udg Healthcare (LON:UDG)‘s stock had its “add” rating reiterated by research analysts at Peel Hunt in a research report issued to clients and investors on Tuesday. They presently have a GBX 880 ($11.84) price objective on the stock. Peel Hunt’s price objective points to a potential downside of 1.23% from the company’s previous close.

Other equities analysts have also recently issued research reports about the stock. N+1 Singer increased their price objective on shares of Udg Healthcare from GBX 770 ($10.36) to GBX 841 ($11.32) and gave the company a “hold” rating in a research note on Wednesday, November 1st. Jefferies Group increased their price objective on shares of Udg Healthcare from GBX 830 ($11.17) to GBX 855 ($11.51) and gave the company a “hold” rating in a research note on Wednesday, October 4th. Stifel Nicolaus restated a “hold” rating and issued a GBX 815 ($10.97) price objective on shares of Udg Healthcare in a research note on Thursday, November 30th. Liberum Capital reiterated a “hold” rating and set a GBX 884 ($11.90) target price on shares of Udg Healthcare in a research report on Tuesday, November 28th. Finally, Numis Securities cut shares of Udg Healthcare to a “reduce” rating and set a GBX 765 ($10.30) target price for the company. in a research report on Thursday, November 9th. One investment analyst has rated the stock with a sell rating and six have issued a hold rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of GBX 826.43 ($11.12).

Udg Healthcare (LON UDG) opened at GBX 891 ($11.99) on Tuesday. Udg Healthcare has a one year low of GBX 632.50 ($8.51) and a one year high of GBX 963 ($12.96).

TRADEMARK VIOLATION NOTICE: This news story was first posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this news story on another website, it was stolen and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this news story can be read at https://sportsperspectives.com/2017/12/19/peel-hunt-reiterates-add-rating-for-udg-healthcare-udg.html.

About Udg Healthcare

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.

Analyst Recommendations for Udg Healthcare (LON:UDG)

Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply